======= C12orf49 =======
== Gene Information ==
* **Official Symbol**: C12orf49
* **Official Name**: chromosome 12 open reading frame 49
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=79794|79794]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9H741|Q9H741]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=C12orf49&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C12orf49|Open PubMed]]
* **OMIM**: N/A
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|DUF2054|
|extracellular region|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-4.96|
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-4.09|
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-3.03|
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-2.54|
|[[:results:exp483|FTY720 3μM R08 exp483]]|-1.86|
|[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.77|
|[[:results:exp538|ZLN024 50μM R08 exp538]]|-1.72|
|[[:results:exp242|Radicicol 0.16μM R05 exp242]]|1.77|
|[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|1.84|
|[[:results:exp229|Dimethyloxaloylglycine 100μM R05 exp229]]|1.95|
|[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.98|
|[[:results:exp233|EPZ-5676 30μM R05 exp233]]|2.12|
|[[:results:exp342|Calcium Ionophore 0.4μM R07 exp342]]|2.8|
|[[:results:exp180|Dynasore 10μM R04 exp180]]|2.87|
|[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|3.41|
|[[:results:exp497|Lead acetate 2000μM R08 exp497]]|3.66|
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|5.68|
^Gene^Correlation^
|[[:human genes:s:scap|SCAP]]|0.511|
|[[:human genes:u:unc50|UNC50]]|0.435|
|[[:human genes:s:srebf2|SREBF2]]|0.414|
Global Fraction of Cell Lines Where Essential: 5/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|1/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|1/75|
|lymphocyte|0/16|
|ovary|1/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18982
* **Expression level (log2 read counts)**: 6.65
{{:chemogenomics:nalm6 dist.png?nolink |}}